We present a case of a patient who developed all manifestations of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) acutely following treatment of cutaneous T-cell lymphoma (CTCL, Sezary syndrome) with deoxycoformycin (pentostatin). Symptoms and signs included severe thrombocy
Biochemical consequences of 2′-deoxycoformycin treatment in a patient with T-cell lymphoma. Some unusual findings
✍ Scribed by Dirk de Korte; Willem A. Haverkort; Eleonore F. Van Leeuwen; Dirk Roos; Albert H. Van Gennip
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 606 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Purpose: To evaluate the efficacy and side effects of psolaren with ultraviolet light a (puva) and interferon-alpha-2a (ifn-alpha-2a) in patients with mycosis fungoides (mf) and sézary syndrome (ss). ## Patients and methods: From may 1993 to january 1999, 63 symptomatic patients with all stage
## Abstract ## BACKGROUND Subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is an uncommon type of skin lymphoma. The natural history, optimal treatment strategy, and prognostic factors associated with this malignancy are not well defined. ## METHODS The authors performed a systematic analy